23andMe Holding Co. (MEHCQ)
OTCMKTS
· Delayed Price · Currency is USD
1.455
+0.055 (3.93%)
Apr 25, 2025, 4:00 PM EDT
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $39.03 million as of April 25, 2025. Its market cap has decreased by -82.81% in one year.
Market Cap
39.03M
Enterprise Value
20.23M
Revenue
208.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.46
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from 622.97M to 39.03M, a decrease of -93.73%. That is a compound annual growth rate of -46.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 39.03M | -53.52% |
| Dec 31, 2024 | 83.97M | -80.81% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 746.57M |
| Glass House Brands | 500.84M |
| Elite Pharmaceuticals | 450.22M |
| Northwest Biotherapeutics | 443.51M |
| CytoDyn | 284.32M |
| BioStem Technologies | 245.41M |